Your browser doesn't support javascript.
loading
Buschke-Ollendorff syndrome: a novel case series and systematic review.
Pope, V; Dupuis, L; Kannu, P; Mendoza-Londono, R; Sajic, D; So, J; Yoon, G; Lara-Corrales, I.
Afiliação
  • Pope V; Department of Dermatology, Hospital for Sick Children, Toronto, ON, Canada.
  • Dupuis L; Department of Genetics and Metabolics, Hospital for Sick Children, Toronto, ON, Canada.
  • Kannu P; Department of Genetics and Metabolics, Hospital for Sick Children, Toronto, ON, Canada.
  • Mendoza-Londono R; Department of Genetics and Metabolics, Hospital for Sick Children, Toronto, ON, Canada.
  • Sajic D; Department of Dermatology, Hospital for Sick Children, Toronto, ON, Canada.
  • So J; University Health Network and Mount Sinai Hospital, The Fred A. Litwin Family Centre in Genetic Medicine, Toronto, ON, Canada.
  • Yoon G; Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Lara-Corrales I; University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, ON, Canada.
Br J Dermatol ; 174(4): 723-9, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26708699
ABSTRACT
Buschke-Ollendorff syndrome (BOS) is a rare, often benign, autosomal skin disorder. BOS commonly presents with nontender connective tissue naevi and sclerotic bony lesions (osteopoikilosis [OPK]). Herein, we summarize the presenting features of BOS and potential associations by conducting a systematic review of the literature and summarizing a cohort seen at the Hospital for Sick Children (HSC), Toronto, Canada. PubMed was searched using the following terms 'BOS'; 'dermatofibrosis lenticularis'; 'OPK'; 'LEMD3'; 'elastoma'; 'collagenoma'. Only case reports were included, without date or language restrictions. Cases were further narrowed to those where patients or their families had a combination of skin and bony lesions, or a positive genetic test. Data were summarized using frequencies. In total, 594 reports were discovered, of which 546 (92%) were excluded. The remaining 48 accounted for 164 cases. Skin lesions were noted in 24% of cases and bony lesions in 20%, while 54% of patients had both. In 1% of cases the diagnosis was made on genetic testing alone. A family history was noted in 92% of cases. All patients with spinal stenosis (2%) or shortened status (7%) had OPK. Six per cent of patients had neurological problems. However, 50% of the cohort from HSC had cognitive delays, and only cases from 2007 onwards reported cognitive delays (the prevalence was 17% among those cases). This review confirms the classical diagnostic features of BOS. In addition, it highlights a previously unreported association between a shortened stature and OPK, as well as a possible association with cognitive delays.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteopecilose / Dermatopatias Genéticas Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteopecilose / Dermatopatias Genéticas Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article